Metraipolis › archive › dc_01be558bbf34

Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database — Europe PMC PMID:42318455

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42318455
DOI: 10.3389/fonc.2026.1689130
License (as archived): solo-consultazione
Archived: 2026-10-08T13:15:19.989Z
SHA-256 of the archived text: 4ae90af7710caf16a9c0c9663aabef2170409dab32af2a5897167db467ae3469
Stable URL of this page: https://metraipolis.com/documento/dc_01be558bbf34

How to cite

Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database — Europe PMC PMID:42318455 — Europe PMC (en), https://europepmc.org/article/MED/42318455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01be558bbf34 (Metraipolis archive dc_01be558bbf34, sha256 4ae90af7710caf16a9c0c9663aabef2170409dab32af2a5897167db467ae3469)

BibTeX

@misc{dc01be558bbf34,
  title = {Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database — Europe PMC PMID:42318455},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42318455},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01be558bbf34; sha256 4ae90af7710caf16a9c0c9663aabef2170409dab32af2a5897167db467ae3469},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42318455. Agents can read the archived copy with the MCP tool read_document.